Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Identifieur interne : 001C89 ( Ncbi/Checkpoint ); précédent : 001C88; suivant : 001C90Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Auteurs : A. Boireau [France] ; J M Miquet ; P. Dubédat ; M. Meunier ; A. DobleSource :
- Neuroreport [ 0959-4965 ] ; 1994.
English descriptors
- KwdEn :
- 1-Methyl-4-phenylpyridinium (antagonists & inhibitors), 3,4-Dihydroxyphenylacetic Acid (metabolism), Animals, Corpus Striatum (drug effects), Corpus Striatum (metabolism), Dopamine (metabolism), Excitatory Amino Acid Antagonists, Extracellular Space (metabolism), Homovanillic Acid (metabolism), Male, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (drug therapy), Rats, Riluzole, Thiazoles (pharmacology).
- MESH :
- chemical , antagonists & inhibitors : 1-Methyl-4-phenylpyridinium.
- chemical , metabolism : 3,4-Dihydroxyphenylacetic Acid, Dopamine, Homovanillic Acid.
- chemically induced : Parkinson Disease, Secondary.
- drug effects : Corpus Striatum.
- drug therapy : Parkinson Disease, Secondary.
- metabolism : Corpus Striatum, Extracellular Space.
- chemical , pharmacology : Thiazoles.
- Animals, Excitatory Amino Acid Antagonists, Male, Rats, Riluzole.
Abstract
Superfusion of the rat striatum with 100 microM of 1-methyl-4-phenylpyridinium (MPP+) induced a 70-fold increase in dopamine (DA) release and a decrease in the extracellular levels of 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Pretreatment with riluzole (8 mg kg-1, i.p.), a compound that interferes with glutamatergic transmission, partially antagonized the effect of MPP+ on the release of DA, but did not change the effects of this toxin on the efflux of DOPAC and HVA. Riluzole did not affect the increase in DA release induced by MPP+ in vitro. The in vivo efficacy of riluzole on MPP(+)-induced DA release could be due to its central interference with glutamatergic transmission. Our data point to a protective role of riluzole with regard to DA release, a marker of the neuronal impairment induced by MPP+, a pro-parkinsonian neurotoxin.
PubMed: 7865766
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001659
- to stream PubMed, to step Curation: 001618
- to stream PubMed, to step Checkpoint: 001618
- to stream Ncbi, to step Merge: 001C89
- to stream Ncbi, to step Curation: 001C89
Links to Exploration step
pubmed:7865766Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.</title>
<author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A" last="Boireau">A. Boireau</name>
<affiliation wicri:level="1"><nlm:affiliation>Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville, Département Biologie, Vitry-sur-Seine, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville, Département Biologie, Vitry-sur-Seine</wicri:regionArea>
<wicri:noRegion>Vitry-sur-Seine</wicri:noRegion>
<wicri:noRegion>Vitry-sur-Seine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J M" last="Miquet">J M Miquet</name>
</author>
<author><name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P" last="Dubédat">P. Dubédat</name>
</author>
<author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M" last="Meunier">M. Meunier</name>
</author>
<author><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A" last="Doble">A. Doble</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7865766</idno>
<idno type="pmid">7865766</idno>
<idno type="wicri:Area/PubMed/Corpus">001659</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001659</idno>
<idno type="wicri:Area/PubMed/Curation">001618</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001618</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001618</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001618</idno>
<idno type="wicri:Area/Ncbi/Merge">001C89</idno>
<idno type="wicri:Area/Ncbi/Curation">001C89</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C89</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.</title>
<author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A" last="Boireau">A. Boireau</name>
<affiliation wicri:level="1"><nlm:affiliation>Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville, Département Biologie, Vitry-sur-Seine, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville, Département Biologie, Vitry-sur-Seine</wicri:regionArea>
<wicri:noRegion>Vitry-sur-Seine</wicri:noRegion>
<wicri:noRegion>Vitry-sur-Seine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J M" last="Miquet">J M Miquet</name>
</author>
<author><name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P" last="Dubédat">P. Dubédat</name>
</author>
<author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M" last="Meunier">M. Meunier</name>
</author>
<author><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A" last="Doble">A. Doble</name>
</author>
</analytic>
<series><title level="j">Neuroreport</title>
<idno type="ISSN">0959-4965</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>1-Methyl-4-phenylpyridinium (antagonists & inhibitors)</term>
<term>3,4-Dihydroxyphenylacetic Acid (metabolism)</term>
<term>Animals</term>
<term>Corpus Striatum (drug effects)</term>
<term>Corpus Striatum (metabolism)</term>
<term>Dopamine (metabolism)</term>
<term>Excitatory Amino Acid Antagonists</term>
<term>Extracellular Space (metabolism)</term>
<term>Homovanillic Acid (metabolism)</term>
<term>Male</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Parkinson Disease, Secondary (drug therapy)</term>
<term>Rats</term>
<term>Riluzole</term>
<term>Thiazoles (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>1-Methyl-4-phenylpyridinium</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>3,4-Dihydroxyphenylacetic Acid</term>
<term>Dopamine</term>
<term>Homovanillic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Corpus Striatum</term>
<term>Extracellular Space</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Thiazoles</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Excitatory Amino Acid Antagonists</term>
<term>Male</term>
<term>Rats</term>
<term>Riluzole</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Superfusion of the rat striatum with 100 microM of 1-methyl-4-phenylpyridinium (MPP+) induced a 70-fold increase in dopamine (DA) release and a decrease in the extracellular levels of 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Pretreatment with riluzole (8 mg kg-1, i.p.), a compound that interferes with glutamatergic transmission, partially antagonized the effect of MPP+ on the release of DA, but did not change the effects of this toxin on the efflux of DOPAC and HVA. Riluzole did not affect the increase in DA release induced by MPP+ in vitro. The in vivo efficacy of riluzole on MPP(+)-induced DA release could be due to its central interference with glutamatergic transmission. Our data point to a protective role of riluzole with regard to DA release, a marker of the neuronal impairment induced by MPP+, a pro-parkinsonian neurotoxin.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A" last="Doble">A. Doble</name>
<name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P" last="Dubédat">P. Dubédat</name>
<name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M" last="Meunier">M. Meunier</name>
<name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J M" last="Miquet">J M Miquet</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A" last="Boireau">A. Boireau</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001C89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:7865766 |texte= Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:7865766" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |